|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/19 | |
| A61K 47/18 | |||
| A61K 38/27 | |||
| A61K 38/30 |
| (11) | Number of the document | 2501367 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10784450.8 |
| Date of filing the European patent application | 2010-11-17 | |
| (97) | Date of publication of the European application | 2012-09-26 |
| (45) | Date of publication and mention of the grant of the patent | 2015-01-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/006996 |
| Date | 2010-11-17 |
| (87) | Number | WO 2011/060922 |
| Date | 2011-05-26 |
| (30) | Number | Date | Country code |
| 261859 P | 2009-11-17 | US |
| (72) |
GOPINATH, Enona, US
PARK, Susan, US
ARAKAWA, Tsutomu, US
RICHARD, Joėl, FR
FAIS, Fabio, FR
|
| (73) |
IPSEN PHARMA S.A.S.,
65, Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
| (54) | Formulation for HGH and RHIGF-1 combination |
| Formulation for HGH and RHIGF-1 combination |